Harrow Health lost $0.14 per diluted share in fiscal year 2025. This represents an increase of 71.4% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Harrow Health has filed alongside them.
FY2025 annual
EPS (Diluted)-$0.14
YoY+71.4%
Source SEC Filings (10-K/10-Q)Latest period Q1 FY2026, ended Mar 31, 2026ReportedCurrency USD
Annual figures, oldest first. Point at a bar to read its period.
HROWL EPS (Diluted) by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
What was Harrow Health's diluted earnings per share in fiscal year 2025?
Harrow Health lost $0.14 per diluted share in fiscal year 2025.
How fast is Harrow Health's diluted earnings per share growing?
Harrow Health (HROWL) diluted earnings per share rose by 71.4% year over year, from -$0.49 to -$0.14 in fiscal year 2025.
What was Harrow Health's diluted earnings per share in the most recent quarter?
Harrow Health (HROWL) reported -$0.74 in diluted earnings per share in Q1 2026. This represents a decrease of 48.0% from the same quarter a year earlier.
What does diluted earnings per share mean on a financial statement?
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Harrow Health (HROWL) reported on that line in every period on record.
